LRRK2 and Parkinson disease: According to previous reports, familial PD patients harboring the G2019S mutation in the LRRK2 gene were clinically indistinguishable from idiopathic PD, showing similarities in terms of motor deficits [20], clinical features [21,22], and neurochemical phenotypes [23].